These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23212561)

  • 41. Results of a prospective trial to compare normal urine supersaturation in children and adults.
    Defoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Minevich E
    J Urol; 2005 Oct; 174(4 Pt 2):1708-10. PubMed ID: 16148687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
    Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
    Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spot Urinary Citrate Normograms in Children.
    Malaki M; Seyedzadeh SA
    Saudi J Kidney Dis Transpl; 2023 Jan; 34(1):96-99. PubMed ID: 38092721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeated urine analysis in patients with calcium stone disease.
    Bek-Jensen H; Tiselius HG
    Eur Urol; 1998; 33(3):323-32. PubMed ID: 9555561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
    Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
    J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary stone risk factors in the descendants of patients with kidney stone disease.
    Dissayabutra T; Kalpongkul N; Rattanaphan J; Boonla C; Srisa-Art M; Ungjaroenwathana W; Tosukhowong P
    Pediatr Nephrol; 2018 Jul; 33(7):1173-1181. PubMed ID: 29594505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and spot urine risk factors for renal stones in children taking topiramate.
    Corbin Bush N; Twombley K; Ahn J; Oliveira C; Arnold S; Maalouf NM; Sakhaee K
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):884-9. PubMed ID: 23375465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium nephrolithiasis: effect of water hardness on urinary electrolytes.
    Schwartz BF; Schenkman NS; Bruce JE; Leslie SW; Stoller ML
    Urology; 2002 Jul; 60(1):23-7. PubMed ID: 12100915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women.
    Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Piaseu N; Chansirikam S; Puavilai G; Rajatanavin R
    Osteoporos Int; 2000; 11(6):486-92. PubMed ID: 10982163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unilateral hypercalciuria: a stealth culprit in recurrent ipsilateral urolithiasis in children.
    Tasian GE; Ziemba J; Casale P
    J Urol; 2012 Dec; 188(6):2330-5. PubMed ID: 23088966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preservation of urine samples for metabolic evaluation of stone-forming patients.
    Ferraz RR; Baxmann AC; Ferreira LG; Nishiura JL; Siliano PR; Gomes SA; Moreira SR; Heilberg IP
    Urol Res; 2006 Oct; 34(5):329-37. PubMed ID: 16896690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 24-h urine metabolic profile: is it necessary in all kidney stone formers?
    Abu-Ghanem Y; Shvero A; Kleinmann N; Winkler HZ; Zilberman DE
    Int Urol Nephrol; 2018 Jul; 50(7):1243-1247. PubMed ID: 29876775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
    Laube N; Rodgers A; Allie-Hamdulay S; Straub M
    Clin Chem Lab Med; 2008; 46(8):1134-9. PubMed ID: 18578688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.